# A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus

> **NCT01862939** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 52 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** DS-7309
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01862939
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2013-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01862939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01862939, "A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT01862939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*